$1.39
4.14% yesterday
NYSE, May 20, 10:07 pm CET
ISIN
US2560861096
Symbol
DCGO

DocGo Stock price

$1.39
-0.68 32.85% 1M
-2.71 66.10% 6M
-2.85 67.22% YTD
-1.65 54.28% 1Y
-4.78 77.47% 3Y
-8.91 86.50% 5Y
-8.91 86.50% 10Y
NYSE, Closing price Tue, May 20 2025
-0.06 4.14%
ISIN
US2560861096
Symbol
DCGO
Sector

Key metrics

Market capitalization $137.76m
Enterprise Value $112.20m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 1.30
EV/Sales (TTM) EV/Sales 0.22
P/S ratio (TTM) P/S ratio 0.26
P/B ratio (TTM) P/B ratio 0.45
Revenue growth (TTM) Revenue growth -26.00%
Revenue (TTM) Revenue $520.50m
EBIT (operating result TTM) EBIT $-1.18m
Free Cash Flow (TTM) Free Cash Flow $86.28m
Cash position $79.01m
EPS (TTM) EPS $-0.01
P/E forward negative
P/S forward 0.44
EV/Sales forward 0.36
Short interest 6.69%
Show more

Is DocGo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

DocGo Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a DocGo forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a DocGo forecast:

Buy
57%
Hold
43%

Financial data from DocGo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
521 521
26% 26%
100%
- Direct Costs 359 359
27% 27%
69%
162 162
24% 24%
31%
- Selling and Administrative Expenses 135 135
9% 9%
26%
- Research and Development Expense 13 13
13% 13%
2%
14 14
74% 74%
3%
- Depreciation and Amortization 15 15
9% 9%
3%
EBIT (Operating Income) EBIT -1.18 -1.18
103% 103%
0%
Net Profit -0.64 -0.64
103% 103%
0%

In millions USD.

Don't miss a Thing! We will send you all news about DocGo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DocGo Stock News

Neutral
Business Wire
one day ago
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top compani...
Neutral
Seeking Alpha
11 days ago
DocGo, Inc (NASDAQ:DCGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Mike Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Ryan MacDonald - Needham Kieran Ryan - Deutsche Bank Jenny Shen - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all li...
Neutral
Business Wire
12 days ago
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, “The impact of ongoing policy changes in Washington and adjustments to public ...
More DocGo News

Company Profile

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Head office United States
CEO Bienstock Lee
Employees 4,400
Founded 2015
Website www.docgo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today